Uncomplicated Type B Aortic Dissection: A European Multicentre Cross-Sectional Evaluation

Bashir, Mohamad and Jubouri, Matti and Surkhi, Abdelaziz O. and Williams, Ian M. and Davidovic, Lazar B. and Koncar, Igor and Baltrunas, Tomas and Kunt, Aysegul and Tanyeli, Omer and Bayram, Muhammed and Ugur, Murat and Rossi, Giovanni and Stelzmueller, Marie-Elisabeth and Hoksbergen, Arjan W. J. and Jongkind, Vincent and Bertoglio, Luca and Zaca, Sergio and Mansour, Wassim and Sirignano, Pasqualino and D'Oria, Mario and Tolva, Valerio Stefano and Van Herzeele, Isabelle and Klincheva, Milka and Atanasov, Zvonka and Bartoli, Stefano and Bellosta, Raffaello and Chisci, Emiliano and Guagliano, Alberto and Teraa, Martin and Ivak, Peter and Recicarova, Sandra and Pellenc, Quentin and Heijmen, Robin and Pfister, Karin and Piffaretti, Gabriele and Hutchings, Hayley and Holland, Gail and Bailey, Damian M. and Thielmann, Matthias and Jakob, Heinz (2025) Uncomplicated Type B Aortic Dissection: A European Multicentre Cross-Sectional Evaluation. ANNALS OF VASCULAR SURGERY, 114. pp. 340-349. ISSN 0890-5096, 1615-5947

Full text not available from this repository. (Request a copy)

Abstract

Background: A multicentre European randomized control trial-European Uncomplicated Type B Aortic Repair (EU-TBAR) is being developed to compare pre-emptive thoracic endovascular aortic repair (TEVAR) with custom-made devices versus conventional optimal medical therapy. The pretrial set-up is confluent on different pillars, including evaluation of 1) European activity, trends, and governance; 2) outcome reporting; and 3) cost evaluation. This article aimed to demonstrate the observational cross-sectional survey results from participating centers and highlight the risk assessment, activity, practices, and governance of uncomplicated type B aortic dissection (uTBAD). Methods: This observational cross-sectional European survey used a questionnaire that examined the understanding, risk assessment, local governance oversight, and clinical activity of uTBAD. The data were collected and managed using Research Electronic Data Capture (REDCap). Results: Out of 43 surveyed surgeons, 37 (86%) responded within a month from 14 European countries. Most reported low annual uTBAD encounters, with autumn being the most common season for cases. Pre-emptive TEVAR was recommended by 43.2% of participants, who favored subacute intervention timing. The Gore TAG was the most used TEVAR device, and custom devices were available for 73% of respondents. Risk factors for uTBAD were ranked, with 'Rapid Aortic Enlargement' deemed most critical. A majority of centers had protocols and multidisciplinary teams, with most having readily available radiology services. Only 45.9% had transfer services to specialized centers. Conclusions: uTBAD remains a misnomer of a dynamic, ongoing disease process requiring early diagnosis and intervention. Pre-emptive TEVAR in high-risk uTBAD is becoming more common, with encouraging results prompting an expansion of indication criteria to a broader uTBAD population managed conservatively. Nevertheless, further evidence is needed through large randomized controlled trials, mainly European collaboratives, to reach a definitive conclusion on the optimum surgical management of uTBAD.

Item Type: Article
Uncontrolled Keywords: ENDOVASCULAR REPAIR;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Abteilung für Gefäßchirurgie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 27 Mar 2026 08:05
Last Modified: 27 Mar 2026 08:05
URI: https://pred.uni-regensburg.de/id/eprint/67950

Actions (login required)

View Item View Item